Gabriel A Rivera - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Gabriel A Rivera

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Leukemia & Lymphoma|February 27, 2016

Immune checkpoint pathways: perspectives on myeloid malignanciesGabriel A Rivera, Iman Saramipoor Behbahan, Peter L Greenberg

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017

Risk Stratification for Second Primary Lung CancerSummer S Han, Gabriel A Rivera, Martin C Tammemägi, et al.

Scientific Reports|November 25, 2025

High-throughput transcriptomic screening reveals entrectinib as a repositioning opportunity in 19q12 autism spectrum disorderDrishti Guin, Ursula Haditsch, Joseph J Bellucci, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Leukemia & Lymphoma|February 27, 2016

Immune checkpoint pathways: perspectives on myeloid malignanciesGabriel A Rivera, Iman Saramipoor Behbahan, Peter L Greenberg

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2017

Risk Stratification for Second Primary Lung CancerSummer S Han, Gabriel A Rivera, Martin C Tammemägi, et al.

Scientific Reports|November 25, 2025

High-throughput transcriptomic screening reveals entrectinib as a repositioning opportunity in 19q12 autism spectrum disorderDrishti Guin, Ursula Haditsch, Joseph J Bellucci, et al.

Pageof 1